USE OF A MODIFIED BACULOVIRUS CONTAINING EXOGENOUS NUCLEIC ACID FOR THE MANUFACTURE OF A MEDICAMENT FOR DELIVERING SAID NUCLEIC ACID TO THE HEPATOCYTES - Patent 0979106

(19)

(11)

EP 0 979 106 A1

(12)

(43)	Date of publication:
	16.02.2000 Bulletin 2000/07

(21)	Application number: 98919340.4

(22)	Date of filing: 29.04.1998

(51)	International Patent Classification (IPC)⁷: A61K 48/00, C12N 15/86

(86)	International application number:
	PCT/GB9801/249

(87)	International publication number:
	WO 9848/842 (05.11.1998 Gazette 1998/44)

(84)	Designated Contracting States:
	BE DE ES FR GB IT NL

(30)

Priority:

29.04.1997 GB 9708698

(71)	Applicant: IMPERIAL COLLEGE INNOVATIONS LIMITED
	London SW7 2AZ (GB)

(72)	Inventors:
	MCGARVEY, Michael, Joseph London N13 4LS (GB) THOMAS,Howard Christopher,Imperial School of Med. London W2 1PG (GB)

(74)	Representative: Chapman, Paul William et al
	Kilburn & Strode,20 Red Lion Street London WC1R 4PJ London WC1R 4PJ (GB)

(54)	USE OF A MODIFIED BACULOVIRUS CONTAINING EXOGENOUS NUCLEIC ACID FOR THE MANUFACTURE OF A MEDICAMENT FOR DELIVERING SAID NUCLEIC ACID TO THE HEPATOCYTES